TORONTO, March 01, 2018 -- Titan Medical Inc. (TSX:TMD) (OTCQB:TITXF) (“Titan” or “the Company), a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery (“MIS”), today announced that David McNally, President and CEO of the Company, will present a corporate overview at the 30th Annual ROTH Conference on Monday, March 12 at 8:00 a.m. PST. The conference will be held March 11-13, 2018 at The Ritz Carlton, Laguna Niguel in Orange County, CA.
Mr. McNally’s presentation will be webcast live and available for replay in the Investors section of Titan Medical’s website at titanmedicalinc.com/investors.
About Titan Medical Inc.
Titan Medical Inc. is a Canadian public company focused on research and development through to the planned commercialization of computer-assisted robotic surgical technologies for application in minimally invasive surgery. The Company is currently developing the SPORT Surgical System, a single-port robotic surgical system. The SPORT Surgical System is comprised of a surgeon-controlled patient cart that includes a 3D high definition vision system and multi-articulating instruments for performing MIS procedures, and a surgeon workstation that provides the surgeon with an advanced ergonomic interface to the patient cart and a 3D endoscopic view inside the patient’s body during MIS procedures. With the SPORT Surgical System, the Company aims to pursue a broad set of surgical indications, including general abdominal, gynecologic and urologic procedures.
For more information, please visit the Company’s website at www.titanmedicalinc.com.
Contacts:
LHA
Kim Sutton Golodetz
(212) 838-3777
[email protected]
or
Bruce Voss
(310) 691-7100
[email protected]
170 University Avenue • Suite 1000
Toronto, Ontario, Canada M5H 3B3 • Tel: 416.548.7522
[email protected] • www.titanmedicalinc.com


SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations
Nintendo Shares Jump as Switch 2 Sales Boost Earnings
Airbnb Stock Jumps After Q2 Earnings Beat, Strong 2026 Outlook
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
Siemens Energy Q3 Profit Beats Forecast as AI-Driven Power Demand Fuels Growth
Alphabet Stock Slides as Google AI Pioneer Jeff Dean Exits to Launch Discovery Loop
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users
Nvidia to Invest Up to $3 Billion in Blackstone-Backed Lancium
DeepSeek to Raise AI API Prices as Demand for New Models Surges
Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised
Berkshire Hathaway Cash Falls as Abel Boosts Stock Buybacks
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns
DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results
Meta AI Model Exploits Security Flaw During Cybersecurity Test, Raising AI Safety Concerns 



